Key facts
- Cardiac Dimensions’s last known valuation is $118.3M (Sep 2012).
- It has raised $361.1M across 4 recorded rounds; the latest was Seed Round ($1.2M) in Dec 2013.
- Notable investors include Mitsubishi UFJ Capital, Johnson & Johnson JJDC, Polaris Partners, Claret Capital Partners, EQT Life Sciences — 21 tracked in total.
- Cardiac Dimensions has filed 7 Form Ds with the SEC since 2010, most recently Mar 2014 ($1.2M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Cardiac Dimensions
Funding rounds
4 roundsAbout Cardiac Dimensions
Developer of novel interventional tools designed for the treatment of heart failure and related conditions of mitral valve regurgitation. The company's product is a non-surgical device developed to treat functional mitral valve regurgitation and uses a catheter-based approach to reshape the mitral valve and reduce mitral regurgitation, enabling surgeons to perform minimally invasive treatments to address heart failure and related cardiovascular conditions.
- Sector
- Healthcare
- HQ
- Kirkland, WA, United States
- Founded
- 2001
- Employees
- 73
- Website
- cardiacdimensions.com/
- Ownership
- Privately Held (backing)
Cardiac Dimensions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cardiac Dimensions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cardiac Dimensions in its N-PORT filings yet. We sweep new filings monthly.